The purchase gives Biogen full access to an implantable device designed to help patients avoid the repeat lumbar punctures required for medicines like Spinraza.

Biogen has agreed to buy development partner Alcyone Therapeutics for an initial payment of $85 million. Biogen on Thursday said the deal also includes potential development and regulatory milestone ...

Biogen to drive end-to-end development and commercialization of ThecaFlex DRx™, an investigational implantable device for ...

Biogen acquires Alcyone Therapeutics to secure ThecaFlex DRx, boosting its drug-device solutions for spinal muscular atrophy.

Biogen has given Alcyone Therapeutics a starring role in its drug delivery strategy, paying $85 million to buy the biotech and take control of an implant for getting medicines into the spinal canal.

Biogen (BIIB) entered into a definitive agreement to acquire Massachusetts-based Alcyone Therapeutics. As part of an existing partnership with ...

US biotech Biogen has entered into a definitive agreement to acquire Massachusetts-based Alcyone Therapeutics, a company the ...

Leading KOLs to discuss the unmet needs and current treatment landscapes of idiopathic inflammatory myopathy (IIM), ulcerative colitis (UC), ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the completion of enrollment for REGENERATE MSA-101, its Phase 1 ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: 4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR) ...

Hafþór Júlíus Björnsson breaks his own world deadlift record with a 510 kg lift. Björnsson’s feat challenges the ...

Soleno Therapeutics faces scrutiny over Vykat safety after a patient death. Click here to find out why I rate SLNO a Hold.